BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32874495)

  • 1. Examining the role of phosphorylation of p19
    Msallam M; Sun H; Meledin R; Franz P; Brik A
    Chem Sci; 2020 Jun; 11(21):5526-5531. PubMed ID: 32874495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation-induced unfolding regulates p19
    Kumar A; Gopalswamy M; Wolf A; Brockwell DJ; Hatzfeld M; Balbach J
    Proc Natl Acad Sci U S A; 2018 Mar; 115(13):3344-3349. PubMed ID: 29531090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of proliferation in developing human tooth germs by MSX homeodomain proteins and cyclin-dependent kinase inhibitor p19
    Kero D; Vukojevic K; Stazic P; Sundov D; Mardesic Brakus S; Saraga-Babic M
    Organogenesis; 2017 Oct; 13(4):141-155. PubMed ID: 28933666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential post-transcriptional regulation of two Ink4 proteins, p18 Ink4c and p19 Ink4d.
    Forget A; Ayrault O; den Besten W; Kuo ML; Sherr CJ; Roussel MF
    Cell Cycle; 2008 Dec; 7(23):3737-46. PubMed ID: 19029828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning and characterization of the human p19(INK4d) gene promoter.
    Matsuzaki Y; Miyazawa K; Yokota T; Hitomi T; Yamagishi H; Sakai T
    FEBS Lett; 2002 Apr; 517(1-3):272-6. PubMed ID: 12062451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).
    Zindy F; den Besten W; Chen B; Rehg JE; Latres E; Barbacid M; Pollard JW; Sherr CJ; Cohen PE; Roussel MF
    Mol Cell Biol; 2001 May; 21(9):3244-55. PubMed ID: 11287627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression pattern of the cell cycle inhibitor p19(INK4d) by progenitor cells of the rat embryonic telencephalon and neonatal anterior subventricular zone.
    Coskun V; Luskin MB
    J Neurosci; 2001 May; 21(9):3092-103. PubMed ID: 11312294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypyrimidine tract-binding protein induces p19(Ink4d) expression and inhibits the proliferation of H1299 cells.
    Lin S; Wang MJ; Tseng KY
    PLoS One; 2013; 8(3):e58227. PubMed ID: 23536791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backbone dynamics of the CDK inhibitor p19(INK4d) studied by 15N NMR relaxation experiments at two field strengths.
    Renner C; Baumgartner R; Noegel AA; Holak TA
    J Mol Biol; 1998; 283(1):221-9. PubMed ID: 9761685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected role for p19INK4d in posttranscriptional regulation of GATA1 and modulation of human terminal erythropoiesis.
    Han X; Zhang J; Peng Y; Peng M; Chen X; Chen H; Song J; Hu X; Ye M; Li J; Sankaran VG; Hillyer CD; Mohandas N; An X; Liu J
    Blood; 2017 Jan; 129(2):226-237. PubMed ID: 27879259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclin-dependent kinase inhibitors p19(Ink4d) and p27(Kip1) are coexpressed in select retinal cells and act cooperatively to control cell cycle exit.
    Cunningham JJ; Levine EM; Zindy F; Goloubeva O; Roussel MF; Smeyne RJ
    Mol Cell Neurosci; 2002 Mar; 19(3):359-74. PubMed ID: 11906209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p19 INK4d controls hematopoietic stem cells in a cell-autonomous manner during genotoxic stress and through the microenvironment during aging.
    Hilpert M; Legrand C; Bluteau D; Balayn N; Betems A; Bluteau O; Villeval JL; Louache F; Gonin P; Debili N; Plo I; Vainchenker W; Gilles L; Raslova H
    Stem Cell Reports; 2014 Dec; 3(6):1085-102. PubMed ID: 25458892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-125b modulates megakaryocyte maturation by targeting the cell-cycle inhibitor p19
    Qu M; Fang F; Zou X; Zeng Q; Fan Z; Chen L; Yue W; Xie X; Pei X
    Cell Death Dis; 2016 Oct; 7(10):e2430. PubMed ID: 27763644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein folding and stability of human CDK inhibitor p19(INK4d).
    Zeeb M; Rösner H; Zeslawski W; Canet D; Holak TA; Balbach J
    J Mol Biol; 2002 Jan; 315(3):447-57. PubMed ID: 11786024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic and extrinsic regulation of the proliferation and differentiation of cells in the rodent rostral migratory stream.
    Coskun V; Luskin MB
    J Neurosci Res; 2002 Sep; 69(6):795-802. PubMed ID: 12205673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p19
    Kuang Y; Han X; Cao P; Xiong D; Peng Y; Liu Z; Xu Z; Liang L; Roy M; Liu J; Nie L; Zhang J
    Blood Cells Mol Dis; 2020 Nov; 85():102477. PubMed ID: 32711219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folding mechanism of an ankyrin repeat protein: scaffold and active site formation of human CDK inhibitor p19(INK4d).
    Löw C; Weininger U; Zeeb M; Zhang W; Laue ED; Schmid FX; Balbach J
    J Mol Biol; 2007 Oct; 373(1):219-31. PubMed ID: 17804013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential myeloma cell responsiveness to interferon-alpha correlates with differential induction of p19(INK4d) and cyclin D2 expression.
    Arora T; Jelinek DF
    J Biol Chem; 1998 May; 273(19):11799-805. PubMed ID: 9565604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p19(INK4d) mRNA and protein expression as new prognostic factors in ovarian cancer patients.
    Felisiak-Golabek A; Dansonka-Mieszkowska A; Rzepecka IK; Szafron L; Kwiatkowska E; Konopka B; Podgorska A; Rembiszewska A; Kupryjanczyk J
    Cancer Biol Ther; 2013 Oct; 14(10):973-81. PubMed ID: 24022213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.